Literature DB >> 15644272

Mitochondrial localization of cellular prion protein (PrPC) invokes neuronal apoptosis in aged transgenic mice overexpressing PrPC.

Naomi S Hachiya1, Makiko Yamada, Kota Watanabe, Akiko Jozuka, Takuya Ohkubo, Kenichi Sano, Yoshio Takeuchi, Yoshimichi Kozuka, Yuji Sakasegawa, Kiyotoshi Kaneko.   

Abstract

Recent studies suggest that the disease isoform of prion protein (PrPSc) is non-neurotoxic in the absence of cellular isoform of prion protein (PrPC), indicating that PrPC may participate directly in the neurodegenerative damage by itself. Meanwhile, transgenic mice harboring a high-copy-number of wild-type mouse (Mo) PrPC develop a spontaneous neurological dysfunction in an age-dependent manner, even without inoculation of PrPSc and thus, investigations of these aged transgenic mice may lead to the understanding how PrPC participate in the neurotoxic property of PrP. Here we demonstrate mitochondria-mediated neuronal apoptosis in aged transgenic mice overexpressing wild-type MoPrPC (Tg(MoPrP)4053/FVB). The aged mice exhibited an aberrant mitochondrial localization of PrPC concomitant with decreased proteasomal activity, while younger littermates did not. Such aberrant mitochondrial localization was accompanied by decreased mitochondrial manganese superoxide dismutase (Mn-SOD) activity, cytochrome c release into the cytosol, caspase-3 activation, and DNA fragmentation, most predominantly in hippocampal neuronal cells. Following cell culture studies confirmed that decrease in the proteasomal activity is fundamental for the PrPC-related, mitochondria-mediated apoptosis. Hence, the neurotoxic property of PrPC could be explained by the mitochondria-mediated neuronal apoptosis, at least in part.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644272     DOI: 10.1016/j.neulet.2004.10.044

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

2.  Low density subcellular fractions enhance disease-specific prion protein misfolding.

Authors:  James F Graham; Sonya Agarwal; Dominic Kurian; Louise Kirby; Teresa J T Pinheiro; Andrew C Gill
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

3.  Do prion protein gene polymorphisms induce apoptosis in non-mammals?

Authors:  Tuğçe Birkan; Mesut Şahin; Zubeyde Öztel; Erdal Balcan
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

4.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Authors:  Zuzana Sisková; Don Joseph Mahad; Carianne Pudney; Graham Campbell; Mark Cadogan; Ayodeji Asuni; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis.

Authors:  Maurizio Sorice; Vincenzo Mattei; Vincenzo Tasciotti; Valeria Manganelli; Tina Garofalo; Roberta Misasi
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

6.  Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution.

Authors:  Vincenzo Mattei; Paola Matarrese; Tina Garofalo; Antonella Tinari; Lucrezia Gambardella; Laura Ciarlo; Valeria Manganelli; Vincenzo Tasciotti; Roberta Misasi; Walter Malorni; Maurizio Sorice
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

7.  Cytosolically expressed PrP GPI-signal peptide interacts with mitochondria.

Authors:  Gianni Guizzunti; Chiara Zurzolo
Journal:  Commun Integr Biol       Date:  2015-05-27

Review 8.  Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Authors:  Marcus W Brazier; Anthony G Wedd; Steven J Collins
Journal:  Antioxidants (Basel)       Date:  2014-04-21

9.  In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms.

Authors:  Pedro Fernandez-Funez; Sergio Casas-Tinto; Yan Zhang; Melisa Gómez-Velazquez; Marco A Morales-Garza; Ana C Cepeda-Nieto; Joaquín Castilla; Claudio Soto; Diego E Rincon-Limas
Journal:  PLoS Genet       Date:  2009-06-05       Impact factor: 5.917

10.  Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.

Authors:  Gui-Ru Wu; Tian-Chen Mu; Zhen-Xing Gao; Jun Wang; Man-Sun Sy; Chao-Yang Li
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.